2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine (CAS No: 90213-66-4) is a key pharmaceutical intermediate used in the synthesis of APIs Tofacitinib citrate, Tofacitinib, Ruxolitinib and Baricitinib. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: 2,6-Dichloro-7-deazapurine, Tofacitinib Impurity 08
CAS No: 90213-66-4
PubChem CID: 14116871
Mol Formula: C6H3Cl2N3
Mol Weight: 188.01 g/mol
Used in APIs: Tofacitinib citrate, Tofacitinib, Ruxolitinib and Baricitinib
IUPAC Name: 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine
API Intermediate Description: 2,4-Dichloro-7H-pyrrolo(2,3-d)pyrimidine is a versatile heterocyclic compound widely used as a key pharmaceutical intermediate and biochemical reagent. It serves as a crucial building block in the synthesis of various biologically active molecules, particularly antiviral and anticancer agents.
![2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine](https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=14116871&t=l)
